Finance

Lists
Outlook: 36.7% bullish·16.7% bearish
Go to analysis
UNH:NYSE
UnitedHealth Group Inc
$376.32
-0.60%
(-2.26) 1D
$376.18
-0.04% (-0.14)
After hours
Closed: Oct 6, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UNH...
Open
$379.03
High
$380.41
Low
$373.70
Mkt. cap
331.82B
Avg. vol.
4.76M
Volume
5.04M
Dividend
2.47%
Quarterly dividend
$2.32
Ex-dividend date
Sep 14, 2026
P/E ratio
24.20
52-wk high
$461.62
52-wk low
$255.96
EPS
$15.55
Beta
0.60
Shares outstanding
897.60M
No. of employees
390K
Open
$379.03
High
$380.41
Low
$373.70
Mkt. cap
331.82B
Avg. vol.
4.76M
Volume
5.04M
Dividend
2.47%
Quarterly dividend
$2.32
Ex-dividend date
Sep 14, 2026
P/E ratio
24.20
52-wk high
$461.62
52-wk low
$255.96
EPS
$15.55
Beta
0.60
Shares outstanding
897.60M
No. of employees
390K
News stories
From web sources and news partners
About UnitedHealth Group Inc
CEOStephen J. Hemsley
Employees390K
FoundedJan 1977
Headquarters-
SectorHealth care provider
Websiteunitedhealthgroup.com
Analyst ratings
Based on 21 analysts giving stock ratings to UNH in the past 3 months
Strong buy
Buy
17
Hold
4
Sell
0
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for UNH in the last 3 months.
Highest
Current $376.32
$529.00 (+40.57%)
Average
$487.22 (+29.47%)
Lowest
$430.00 (+14.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lance Wilkes
Bernstein
Buy
Maintained
$512.00
+36.1%
10/05/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
$490.00
+30.2%
10/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$526.00
+39.8%
09/15/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$480.00
+27.6%
09/14/2026
A.J. Rice
UBS
Buy
Maintained
$490.00
+30.2%
09/14/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$441.00
+17.2%
09/10/2026
Hans Engel
Erste Group
Hold
Downgraded
-
-
08/27/2026
George Hill
Deutsche Bank
Hold
Maintained
-
-
08/03/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$516.00
+37.1%
07/21/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$493.00
+31%
07/21/2026
Ryan Langston
TD Cowen
Hold
Maintained
$430.00
+14.3%
07/19/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$478.00
+27%
07/16/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$529.00
+40.6%
07/17/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$512.00
+36.1%
07/17/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
07/17/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$500.00
+32.9%
07/17/2026
David Toung
Argus Research
Buy
Maintained
$470.00
+24.9%
07/17/2026
Michael Ha
Robert W. Baird
Hold
Upgraded
$453.00
+20.4%
07/17/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$500.00
+32.9%
07/17/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$475.00
+26.2%
07/15/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$475.00
+26.2%
07/14/2026
Sidharth Sahoo
HSBC
Hold
Maintained
$380.00
+1%
07/06/2026
Michael Craig Jones
Bank of America Securities
Buy
Reiterated
$475.00
+26.2%
06/24/2026
John Ransom
Raymond James
Buy
Maintained
$370.00
-1.7%
04/22/2026
David Windley
Jefferies
Buy
Maintained
$373.00
-0.9%
04/20/2026
Bram Kaplan
J.P. Morgan
Buy
Maintained
$389.00
+3.4%
02/02/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$440.00
+16.9%
01/28/2026
Next call in 6 days
Tue, Oct 13, 8:00 AM
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $4.15
Revenue / Est. (USD)
- / 111.49B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
113.16B
113.61B
111.72B
112.03B
Cost of goods sold
92.52B
94.10B
86.31B
88.73B
Cost of revenue
92.52B
94.10B
86.31B
88.73B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.22B
15.60B
15.39B
14.27B
Operating expense
16.32B
16.71B
16.42B
15.31B
Total operating expenses
108.85B
110.81B
102.73B
104.04B
Operating income
4.32B
2.80B
8.99B
7.99B
Other non operating income
-
-
-
-
EBT including unusual items
3.23B
-720.00M
7.96B
6.97B
EBT excluding unusual items
3.31B
1.83B
8.04B
7.03B
Income tax expense
686.00M
-938.00M
1.48B
1.30B
Effective tax rate
21.24%
130.28%
18.61%
18.63%
Other operating expenses
-
-
-
-
Net income
2.35B
10.00M
6.28B
5.48B
Net profit margin
2.07%
0.01%
5.62%
4.89%
Earnings per share
2.92
2.11
7.23
6.38
Interest and investment income
-
-
-
-
Interest expense
-1.00B
-974.00M
-955.00M
-962.00M
Net interest expenses
-1.00B
-974.00M
-955.00M
-962.00M
Depreciation and amortization charges
1.10B
1.12B
1.03B
1.04B
EBITDA
5.41B
3.92B
10.02B
9.03B
Gain or loss from assets sale
83.00M
-784.00M
72.00M
61.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps